Commitment to Epilepsy

Aquestive is a specialty pharmaceutical company that advances and commercializes medicines to solve therapeutic problems and meaningfully improve people's lives. Aquestive has focused on applying its technology to address unmet patient needs in CNS conditions, including epilepsy. The Company's first proprietary commercial product was approved by the FDA for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS). The Company is also investigating Libervant™ (diazepam buccal film) as a novel, fast-acting, oral rescue treatment for increased bouts of seizure activity.

Advocacy relationships

Aquestive works with patient advocacy organizations to gain insights into patient needs; to provide accurate, timely and helpful information on our products; and to identify and improve resources that support patients and caregivers throughout their treatment journey. We know that strong patient communities are an essential lifeline to individual families seeking better care and outcomes.

Logo. Multicolored palm prints in background. Copy in the foreground reads

Supporting the Lennox-Gastaut syndrome (LGS) community

The Art of Living with LGS is a community art project that was organized by Aquestive as a way to help families with LGS share advice, inspiration, and experiences with others. The event debuted at the 6th International Family and Professional Conference on Lennox-Gastaut syndrome. Together, the LGS community created not just art, but also the picture of a better life for all those living with LGS.

The Art of LGS​ Video

The Art of LGS Book

People with LGS have another choice for treatment

New product under investigation

Please complete this form:

  • To subscribe to receive information updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing info@aquestive.com or by calling 1-908-941-1900.

Please complete the form below and click SEND to receive a copy of “Overcoming Solubility and Permeability Challenges,” a case study detailing the achievements made by Aquestive’s formulation team to create the diazepam buccal film.

  • To subscribe to receive marketing updates about diazepam buccal film and other products and services from Aquestive, please complete the form below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing busdev@aquestive.com.

Please complete the form to receive a demonstration kit for our PharmFilm® technology.

  • To subscribe to receive marketing updates about our PharmFilm® technology and other products and services from Aquestive, please complete the form below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing busdev@aquestive.com.

Please complete this form:

  • To subscribe to receive marketing updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. If for any reason you no longer wish to receive information on Aquestive-sponsored clinical trials, you can contact us at any time by emailing clinicaltrials@aquestive.com.

Whether we are partnering to out license our PharmFilm® technology or in-licensing adjacent assets, Aquestive works hand-in-hand with our partners to address their toughest clinical and business challenges. To learn more, please complete the following form:

  • To subscribe to receive information updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing busdev@aquestive.com.

Please complete the form below and click submit to receive a copy of “The Art of LGS Book.”